Skip to main content

Linnaeus Therapeutics

Haddonfield, United States

Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.

$5.0M raised
Feb 2026
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Linnaeus Therapeutics

How much funding has Linnaeus Therapeutics raised?
Linnaeus Therapeutics has raised $5.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2026.
Who are Linnaeus Therapeutics's investors?
Linnaeus Therapeutics's investors include Advanced Research Projects Agency for Health, Kairos Ventures, National Cancer Institute, Penn Medicine Co-Investment Program.
Where is Linnaeus Therapeutics headquartered?
Linnaeus Therapeutics is headquartered in Haddonfield, United States.
What does Linnaeus Therapeutics do?
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
What stage is Linnaeus Therapeutics at?
Linnaeus Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Linnaeus Therapeutics — Funding & Investors." VCBacked, February 27, 2026, https://www.vcbacked.co/company/linnaeus-therapeutics. Accessed July 3, 2026.
APA
VCBacked. (2026). Linnaeus Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/linnaeus-therapeutics
Wikipedia (cite web)
{{cite web |title=Linnaeus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/linnaeus-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .